Review more supports the enlargement of medical trials of MYCO-001 for the treatment method of PTSD between the Veteran inhabitants DENVER, Jan. 24, 2022 (Globe NEWSWIRE) — Mydecine Improvements Team (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology and electronic technology firm aiming to rework the […]
Sunday, Feb 2, 2025
Breaking News